

Call for papers
20 years of the World Anti-Doping Code in Action
International Sports Law Journal Conference 2025
Asser Institute, The Hague
6 and 7 November 2025
The Editors of the International Sports Law Journal (ISLJ), the Asser Institute and the Research Chair on Responsible Sport of the University of Sherbrooke invite you to submit abstracts for the ISLJ Conference on International Sports Law, which will take place on 6 and 7 November 2025 at the Asser Institute in The Hague. The ISLJ, published by Springer and T.M.C. Asser Press, is the leading academic publication in the field of international sports law and governance. The conference is a unique occasion to discuss the main legal issues affecting international sports with academics and practitioners from all around the world.
The 2025 ISLJ Conference will focus on assessing the first 20 years (2004-2024) of operation of the World Anti-Doping Code (WADC) since its entry into force in 2004, while also discussing its future prospects, in light of the new version of the Code due to be adopted at the Busan Conference in December 2025 and the 10th Conference of the Parties to the International Convention against Doping in Sport, to be held in Paris from 20 to 22 October. The aim of the conference will be to take a comprehensive stock of the operation of the private-public transnational regulatory regime which emerged in the wake of the WADC. This regime is structured around a complex network of national and global institutions engaged in anti-doping work (WADA, NADAs, IFs, accredited laboratories) and guided by an equally complex assemblage of norms located at the global (WADC and the WADA Standards), international (UNESCO Convention against Doping in Sport), regional (Council of Europe Anti-Doping Convention), and national (various national anti-doping legislations) level. This makes for a fascinating and convoluted transnational legal construct in need of being studied, analysed and criticised by scholars.
Reviewing 20 years of implementation of the WADC warrants a special edition of the ISLJ Conference and of the journal, which invites scholars of all disciplines to reflect on the many questions and issues linked with it. We welcome proposals touching on the following subjects (and more):
- The governance of the world anti-doping regime
- The public-private nature of this governance
- The transparency of this governance
- The legitimacy of this governance
- The participatory nature of this governance
- The role of scientific experts in this governance
- The normative content of the WADC and the international standards
- The strict liability principle
- The privacy rights of athletes under the WADC
- The sanctioning policy under the WADC
- The role of the international standards in implementing the WADC
- The compatibility of the WADC with human rights
- The glocal implementation of the WADC
- The role of local institutions (NADOs/Labs/NOCs) in the implementation of the WADC
- The tension between global (WADA) and local (NADOs/Labs/NOCs) in the implementation of the WADC
- The role of the IFs in the implementation of the WADC
- The role of the ITA in the implementation of the WADC
- The role of judicial bodies (national courts, disciplinary committees of IFs, CAS) and their jurisprudence in the implementation of the WADC
- The effectiveness of the world anti-doping regime
- The evaluation and evolution of the effectiveness of the world anti-doping regime in preventing doping
- The role of the media in unveiling the ineffectiveness of the world anti-doping regime
- The role of states in hindering the effectiveness of the world anti-doping regime
- The world anti-doping regime as a regime with a variable geometry of effectiveness
- The future of the world anti-doping regime: Revolution, reform or more of the same?
- Do we need a world anti-doping regime?
- If we do, should it be reformed? How?
Abstracts of 300 words and CVs should be sent no later than 1 June 2025 to a.duval@asser.nl. Selected speakers will be informed by 30 June 2025. The selected participants will be expected to submit a draft paper by 15 October 2025. Papers accepted and presented at the conference are eligible for publication in a special issue of the ISLJ subject to peer-review. The Asser Institute will provide a limited amount of travel and accommodation grants (max. 350€) to early career researchers (doctoral and post-doctoral) in need of financial support. If you wish to be considered for a grant, please indicate it in your submission.
Editor's note: Marjolaine is a researcher and attorney admitted to the Geneva bar (Switzerland) who specialises in sports and life sciences.
I.
Introduction
The COVID-19 pandemic has shaken the manner
in which we approach human interactions that suppose close and prolonged physical
contact. Across the world, authorities are having to design ways to resume
essential activities without jeopardising participants’ health, all the while
guaranteeing that other fundamental rights are paid due respect. The fight
against doping is no exception. Anti-doping organizations – whether public or
private – have to be held to the same standards, including respect for physical
integrity and privacy, and considerate application of the cornerstone principle
of proportionality.
Throughout this global crisis, the World
Anti-Doping Agency (‘WADA’) has carefully monitored the situation, providing
anti-doping organizations and athletes with updates and advice. On
6 May 2020, WADA issued the document called ‘ADO
Guidance for Resuming Testing’ (‘COVID Guidance’). A COVID-19
‘Q&A’ for athletes (‘Athlete Q&A’) is also available on WADA’s
website, and has been last updated on 25 May 2020. This article focuses on
these two latest documents, and analyses the solutions proposed therein, and
their impact on athletes.
Like many public or private recommendations
issued for other societal activities, the WADA COVID Guidance is primarily
aimed at conducting doping control while limiting the risk of transmission of
the virus and ensuing harm to individuals. More specifically, one can identify two
situations of interest for athletes that are notified for testing:
- The athlete has or suspects
that they may have been infected with COVID-19, or has come in close contact
with someone having COVID-19;
- The athlete fears to be in
touch with doping control personnel that may be infected with COVID-19.
Quite obviously, either situation has the
potential to create significant challenges when it comes to balancing the
interests of anti-doping, with individual rights and data protection concerns.
This article summarises how the latest WADA COVID Guidance and Athlete Q&A
address both situations. It explores how the solutions suggested fit in with
the WADA regulatory framework and how these might be assessed from a legal
perspective.
The focus will be on the hypothesis in
which international sports federations – i.e. private entities usually
organised as associations or similar structures – are asked to implement the COVID
Guidance within their sport. National anti-doping organizations are strongly
embedded in their national legal system and their status and obligations as
public or semi-public organisations are likely to be much more dependent on the
legislative landscape put in place to deal with the COVID-19 pandemic in each
country. Nevertheless, the general principles described in this article would
apply to all anti-doping organizations alike, whether at international or
national level. More...